Natural and synthetic isoflavones in the prevention and treatment of chronic diseases M. L. Brandi OriginalPaper Pages: S5 - S8
Ipriflavone inhibits bone resorption in intact and ovariectomized rats M. G. CecchiniH. FleischR. C. Mühlbauer OriginalPaper Pages: S9 - S11
In Vitro and In Vivo effects of ipriflavone on bone formation and bone biomechanics R. Civitelli OriginalPaper Pages: S12 - S14
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists M. GambaccianiB. CappagliA. R. Genazzani OriginalPaper Pages: S15 - S18
Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass C. GennariS. AdamiL. Vecchiet OriginalPaper Pages: S19 - S22
Efficacy of ipriflavone in established osteoporosis and long-term safety D. AgnusdeiL. Bufalino OriginalPaper Pages: S23 - S27
Design for an ipriflavone multicenter European fracture study J. Y. ReginsterL. BufalinoC. Roux OriginalPaper Pages: S28 - S32
The future of ipriflavone in the management of osteoporotic syndromes L. V. Avioli OriginalPaper Pages: S33 - S35